MIM
EW icon

Macroview Investment Management’s Edwards Lifesciences EW Stock Holding History

Macroview Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8
Closed -$555 – 697
2023
Q3 		$555 Sell
8
-118
-94% -$9.48K ﹤0.01% 716
2023
Q2 		$11.9K Buy
+126
New +$11K 0.02% 216
2020
Q2 		– Sell
-42
Closed -$3K – 339
2020
Q1 		$3K Buy
42
+6
+17% +$433 0.01% 173
2019
Q4 		$3K Buy
+36
New +$2.81K 0.01% 231

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Macroview Investment Management's EW Position: Q4 2023 in Review

Macroview Investment Management sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 8 shares — an estimated $555 sold.

Macroview Investment Management first reported a position in EW in Q4 2019 and held it in 4 quarters. The position peaked at $11.9K in Q2 2023. 1,245 funds tracked by Wall St. Rank hold EW as of Q4 2023.

  • Macroview Investment Management reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
  • Macroview Investment Management sold 8 Edwards Lifesciences shares in Q4 2023, an estimated $555.
  • Macroview Investment Management first reported a position in Edwards Lifesciences in Q4 2019 and held it in 4 quarters.
  • Macroview Investment Management's Edwards Lifesciences position peaked at $11.9K in Q2 2023.
  • 1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Macroview Investment Management's 13F filing for Q4 2023, filed 30 Jan 2024.